Novel cell-penetrating-amyloid peptide conjugates preferentially kill cancer cells.
Medchemcomm. 2017 Dec 5;9(1):121-130. doi: 10.1039/c7md00321h. eCollection 2018 Jan 1.
Medchemcomm. 2017.
PMID: 30108906
Free PMC article.